( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57



Dr. Mansi Grewal*, Dr. Yogesh Kumar Pandey


Introduction: COVID-19 manifests as varied clinical features affecting different organ systems. In post-COVID state, patients often present with post-viral fatigue, dyspnea, olfactory and/or gustatory dysfunction, depressive mood and behavior, thrombotic events, cardiac complications, etc. These can be managed on principles of jwara, raktapitta, shwasa, vatavyadhi, marmopghata. Aim: To understand presenting features of post-COVID-19 illness through principles of ayurveda and devise a preventive and therapeutic plan for the same. Methodology: LitCovid engine, google scholar, WHO website, ayurvedic texts are searched with specific keywords and evidence gathered is critically analyzed on therapeutic concepts of remnant dosha post Sannipataja Jwara, secondary Raktapitta, Shwas resulting in urah shushkta, marmopghata, oja, and vyadhi sankara etc. Results and discussion: Post-COVID manifestations bear resemblance to concepts of depletion in oja, state of asanjaat bala post jwara, remnant doshas post jwara, shotha complications, urah shushkta due to shwasa, shira and hridya marmopghata, indriya santapa, rakta vitiation, raktapitta, bhaishaj vyapad, kleda and krimi. Preventive measures should be propagated. Preexisting co-morbidities must be checked for and dashvidha rogi pariksha should be done to assess atura and dosha bala in order to assess prognosis and decide dosage of therapeutics. Treatment should be started after proper evaluation of roga avastha, rogi and roga bala, status of prana. Outcomes of therapeutic regime can be evaluated through examination of characteristics of vikaropshaman reflective of dhatusamyata. Conclusion: Post-COVID illnesses manifest differently in different people. Underlying process of delayed recovery, continuous inflammation, altered coagulation, and profibrotic mechanisms are common culprits. These pathologies have a notorious history of becoming chronic autoinflammatory, autoimmune diseases. Multiple viral illnesses are known triggers for such inflammatory disorders. Therefore it is essential to prevent and manage all updrava, vyadhi sankara, and especially diseases of vital organs through timely assessment of rogi-roga avastha and bala.

Keywords: Ayurveda, Jwara, post-COVID.

[Full Text Article] [Download Certificate]


  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 July 2024 Issue has been Published, Kindly check it on


    JULY 2024 issue has been successfully launched on JULY 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia